Acelrx Pharmaceuticals Inc. buy tamam
Start price
23.10.18
/
50%
€70.72
Target price
23.04.19
€131.69
Performance (%)
-13.27%
End price
23.04.19
€61.34
Summary
This prediction ended on 23.04.19 with a price of €61.34. The price of Acelrx Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.27%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acelrx Pharmaceuticals Inc. | 5.405% | 5.405% | 230.508% | 31.313% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by tamam for this prediction
In the thread Acelrx Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von stratec zu
tamam stimmt am 23.10.2018 der Buy-Einschätzung von stratec mit dem Kursziel 7,3$ zu.
Überschrift: ACRX PDUFA action date November 3, 2018, for sufentanil for the management of moderate-to-severe pain
(Laufzeit überschritten)
Stopped prediction by tamam for Acelrx Pharmaceuticals Inc.
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€65.49
24.04.19
24.04.19
€117.26
04.11.21
04.11.21
-77.63%
05.11.21
05.11.21
